DENTSPLY SIRONA Inc. XRAY
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -16.62%
- 1 year
- -24.31%
- Open
- 9.55
- Prev close
- 9.61
- Mkt cap
- 1.90B
- Vol
- 3.50M
- Avg vol
- 4.54M
- EPS
- -2.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.41
- High
- 9.68
- Forward P/E
- 6.45
- Beta
- 0.88
- Short ratio
- 5.59
- Inst. own
- 116.74%
- Dividend
- 0.00
- Ex-div date
- Dec 25, 2025
- Earnings
- Nov 5, 2026
- 50-d avg
- 9.72
- 200-d avg
- 11.34
- 1y target
- 12.40
News
5 days ago prnewswire.com
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
6 days ago benzinga.com
ServiceNow To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for RS, CVLT, SLB, RNG and VEEV; cut targets for XRAY and FUN while maintaining ratings.
-
6 days ago benzinga.com
Barrington Research Maintains Outperform on Dentsply Sirona, Lowers Price Target to $13
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price target from $15 to $13.
-
1 week ago benzinga.com
Mizuho Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.
1 week ago globenewswire.com
Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5
CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and…
-
2 weeks ago benzinga.com
Leerink Partners Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10
Leerink Partners analyst Michael Cherny maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $14 to $10.
2 weeks ago zacks.com
Dentsply Sirona Expands U.S. Digital Dentistry Reach With Midwest Deal
XRAY expands its U.S. distribution reach through Midwest Dental, aiming to boost digital dentistry adoption and broaden access to its technology portfolio.
2 weeks ago defenseworld.net
Dentsply Sirona (NASDAQ: XRAY) secures covenant relief in debt amendments
What happened Dentsply Sirona Inc. (NASDAQ: XRAY) said on October 8, 2026, that lenders consented to amendments to its revolving credit facility and related note agreements. The company entered the…
-
3 weeks ago benzinga.com
Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12
Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.
-
3 weeks ago benzinga.com
Dentsply Sirona Unit Wellspect HealthCare Announces That Its Surity Urinary Management Portfolio May Be Covered By Traditional Medicare For Eligible Beneficiaries When Medically Necessary
This milestone represents an important step in expanding access and reducing barriers to at-home management for people affected by severe urinary incontinence in the U.S. The Surity™ portfolio…
3 weeks ago globenewswire.com
Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio
MÖLNDAL, Sweden, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Wellspect HealthCare today announced that the Surity™ portfolio, including the Surity™ Urinary Management System and Surity™ Female and Male…
3 weeks ago globenewswire.com
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
The expanded relationship builds on a series of agreements announced this year, strengthening Dentsply Sirona's North American dealer network and giving more customers access to its products and…
1 month ago defenseworld.net
DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 1-Year Low – Time to Sell?
Shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) hit a new 52-week low on Friday. The company traded as low as $9.36 and last traded at $9.38, with a volume of 9306449 shares. The…
1 month ago defenseworld.net
Engineers Gate Manager LP Boosts Stake in DENTSPLY SIRONA Inc. $XRAY
Engineers Gate Manager LP boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 451.5% in the undefined quarter, according to the company in its most recent 13F filing with the…
1 month ago zacks.com
Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio for Now
XRAY's digital dentistry, R&D and restructuring support growth, but CAD/CAM, implants, SureSmile and tariff pressures pose near-term risks.
-
1 month ago benzinga.com
BMO Capital Maintains Market Perform on Dentsply Sirona, Lowers Price Target to $10
BMO Capital analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Market Perform and lowers the price target from $13 to $10.
1 month ago zacks.com
XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin Pressure
XRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.
1 month ago prnewswire.com
Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…
1 month ago globenewswire.com
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Baird 2026 Global…
2 months ago youtube.com
Hayes: "950 Billion Reasons" to Buy Bonds, PFE & XRAY Buy Opportunities
"I'll give you 950 billion reasons to buy bonds right now," says Thomas Hayes, who gives a contrarian take on why investors should bolster their portfolios in fixed income. He discusses the…
-
2 months ago benzinga.com
Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11
Barclays analyst Glen Santangelo maintains Dentsply Sirona (NASDAQ:XRAY) with a Underweight and raises the price target from $9 to $11.
2 months ago prnewswire.com
New At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary Incontinence
New system completes the Surity™ portfolio of external catheters for both men and women Integrates into daily routines to help support management of urinary incontinence at home Designed to operate…
2 months ago defenseworld.net
Empowered Funds LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY
Empowered Funds LLC increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 515.3% in the first quarter, according to the company in its most recent disclosure with the Securities and…
2 months ago marketbeat.com
DENTSPLY SIRONA Q2 Earnings Call Highlights
DENTSPLY SIRONA NASDAQ: XRAY reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its…
2 months ago zacks.com
XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales
DENTSPLY SIRONA's Q2 sales fall 4.1% as dental weakness offsets Wellspect growth, while margins improve and 2026 guidance is maintained.
2 months ago zacks.com
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings
The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
2 months ago seekingalpha.com
DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript
DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript
2 months ago zacks.com
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.52 per share a year ago.
-
2 months ago benzinga.com
Dentsply Sirona Affirms FY2026 Adj EPS Guidance of $1.40-$1.50 vs $1.42 Est; Affirms FY2026 Sales Guidance of $3.500B-$3.600B vs $3.582B Est
Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.42 analyst estimate. Affirms FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500…
-
2 months ago benzinga.com
Dentsply Sirona Q2 Adj. EPS $0.52 Beats $0.35 Estimate, Sales $898.000M Beat $889.810M Estimate
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.35 by 48.57 percent. This is unchanged from the same period last year. The…
-
3 months ago benzinga.com
Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14
Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $13 to $14.
-
3 months ago benzinga.com
BMO Capital Initiates Coverage On Dentsply Sirona with Market Perform Rating, Announces Price Target of $12
BMO Capital initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Market Perform rating and announces Price Target of $12.
-
4 months ago benzinga.com
DENTSPLY SIRONA Appoints John Forston CFO, Effective July 20
DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the…
5 months ago benzinga.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Healthcare Stocks Delivering High-Dividend Yields
In turbulent markets, investors turn to dividend-yielding stocks. Here are analyst ratings for high-yielding energy stocks.
-
5 months ago benzinga.com
Dentsply Sirona Expands Collaboration With Nashville Dental To Expand U.S. Distribution Footprint
Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the strengthening of its U.S. distribution footprint…
-
5 months ago benzinga.com
Mizuho Maintains Neutral on Dentsply Sirona, Lowers Price Target to $14
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $16 to $14.
6 months ago benzinga.com
Dentsply Sirona Q1 2026 Earnings Call Transcript
Dentsply Sirona Q1 2026 Earnings Call Transcript
-
6 months ago benzinga.com
Dentsply Sirona Affirms FY2026 Adj EPS Guidance of $1.40-$1.50 vs $1.43 Est; Affirms FY2026 Sales Guidance of $3.500B-$3.600B vs $3.578B Est
Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.43 analyst estimate. Affirms FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500…
-
6 months ago benzinga.com
Dentsply Sirona Q1 Adj. EPS $0.27 Misses $0.28 Estimate, Sales $880.000M Beat $842.589M Estimate
Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.28 by 3.57 percent. This is a 37.21 percent decrease over earnings of…
-
6 months ago benzinga.com
Dentsply Sirona Signs Agreement For Atlanta Dental Supply To Start Offering Dentsply's Connected Technology Solutions Portfolio In U.S. As Of Aug. 1
Dentsply Sirona (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced an enhanced distribution agreement with Atlanta Dental…
-
6 months ago benzinga.com
Citigroup Initiates Coverage On Dentsply Sirona with Sell Rating, Announces Price Target of $10
Citigroup analyst Daniel Grosslight initiates coverage on Dentsply Sirona (NASDAQ:XRAY) with a Sell rating and announces Price Target of $10.
-
7 months ago benzinga.com
Dentsply Sirona And Siemens Announce Dental‑Dedicated MRI Trial Data; MAGNETOM Free.Max Dental Edition Validates Specialized Imaging Features
Dentsply Sirona and Siemens Healthineers are pleased to announce that the first-ever dental-dedicated MRI1 (ddMRI) system – MAGNETOM Free.Max Dental Edition – has received FDA clearance in the United…
8 months ago benzinga.com
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
Investors turn to dividend-yielding stocks during market turbulence. Benzinga offers latest analyst ratings and news on high-yielding stocks in the health care sector, including PRGO and PFE.
8 months ago benzinga.com
These Analysts Boost Their Forecasts On Dentsply Sirona Following Q4 Earnings
Dentsply Sirona (XRAY) reported mixed Q4 results, missing earnings but beating sales estimates. FY2026 projections below market expectations.
-
8 months ago benzinga.com
Mizuho Maintains Neutral on Dentsply Sirona, Raises Price Target to $16
Mizuho analyst Steven Valiquette maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $14 to $16.
-
8 months ago benzinga.com
Barrington Research Maintains Outperform on Dentsply Sirona, Raises Price Target to $17
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and raises the price target from $14 to $17.
8 months ago benzinga.com
Bank, Private-Equity Stock Rout Deepens As AI Fears Mount: What's Moving Markets Friday?
A sharp banking selloff gripped Wall Street on Friday, compounding a week dominated by concerns over artificial intelligence-driven economic disruption. Hotter-than-expected producer price data added…
8 months ago benzinga.com
Autodesk, Arlo Technologies, Beyond Meat, Netflix And Other Big Stocks Moving Higher On Friday
Autodesk Inc (ADSK) rose sharply after beating Q4 earnings & issuing strong guidance. Other gainers include AAOI, NGNE, ARLO, PRAA, BYND, BWIN, PSKY, & DELL.
-
8 months ago benzinga.com
Wells Fargo Maintains Equal-Weight on Dentsply Sirona, Raises Price Target to $13
Wells Fargo analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Equal-Weight and raises the price target from $12 to $13.